Steve Krognes Net Worth & Insider Trades
Steve Krognes - Director, Denali Therapeutics Inc
What is Steve Krognes's Net Worth?
The current estimated net worth of Denali Therapeutics Inc's Director, Steve Krognes, is estimated to be about $38.21M . Steve Krognes owns about 993,002 units of Denali Therapeutics Inc common stock. In the last 6 years at Denali Therapeutics Inc, Steve Krognes has sold an estimated value of $10.99M worth.
What is Steve Krognes's Past Insider Trading?
Steve Krognes's largest sale order was 50,000 units , worth over $3.57M on January 20, 2021. In total, Steve Krognes has made about 25 transactions over 6 years of their time at Denali Therapeutics Inc. Steve Krognes usually trades in February, with the busiest year in 2021. The most recent transaction was a sale order of 2,119 units , worth over $63.78K on February 15, 2023.
Steve Krognes
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Steve Krognes's Salary in 2020?
As Director of Denali Therapeutics Inc, Steve Krognes has a total base salary of $484,200 . Steve Krognes received compensation valued at about $4,266,044 in 2020 after becoming Director. The vast majority of their compensation came in the form of a bonus of $387,362 , stock awards of $1,364,638 , option awards of $2,018,444 , and other compensation of $11,400 .
What is Steve Krognes's' Mailing Address?
- Mailing address is 863 Mitten Road, Suite 102 Burlingame CA 94010 CA
Denali Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Ryan J. Watts, Ph.D. | 2020 | $589,472 | $648,419 | $2,596,305 | $5,456,849 | $11,400 | $9,302,445 |
| Ryan J. Watts, Ph.D. | 2019 | $566,800 | $311,740 | $838,168 | $3,252,452 | $9,447 | $4,978,607 |
| Ryan J. Watts, Ph.D. | 2018 | $545,000 | $524,563 | - | $4,914,360 | - | $5,983,923 |
| Alexander O. Schuth, M.D. | 2020 | $449,400 | $359,520 | $1,364,638 | $2,018,444 | $11,400 | $4,203,402 |
| Alexander O. Schuth, M.D. | 2019 | $428,000 | $171,200 | $305,830 | $1,558,941 | $12,657 | $2,476,628 |
| Alexander O. Schuth, M.D. | 2018 | $400,000 | $355,000 | $179,673 | $2,948,616 | $18,500 | $3,901,789 |
| Steve E. Krognes | 2020 | $484,200 | $387,362 | $1,364,638 | $2,018,444 | $11,400 | $4,266,044 |
| Steve E. Krognes | 2019 | $470,057 | $188,023 | $305,830 | $1,558,941 | $7,834 | $2,530,685 |
| Steve E. Krognes | 2018 | $455,260 | $393,682 | $179,673 | $2,948,616 | $24,000 | $4,001,231 |
| Carole Ho, M.D. | 2020 | $457,600 | $366,080 | $1,382,774 | $2,107,493 | $11,400 | $4,325,347 |
| Carole Ho, M.D. | 2019 | $440,000 | $176,000 | $305,830 | $1,558,941 | $8,800 | $2,489,571 |
| Carole Ho, M.D. | 2018 | $423,124 | $371,187 | $179,673 | $2,948,616 | $12,869 | $3,935,469 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1714899/000171489921000042/fy20def14aproxy.htm
What are Denali Therapeutics Inc's Past Insider Trades?
Denali Therapeutics Inc's most recent insider trade came on February 17, 2023 by Carole Ho who sold 1,476 units worth $43.39K . In the last 6 years, insiders at Denali Therapeutics Inc have sold an estimated value of $444.81M and bought an estimated value of $8.11M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Alexander Schuth, COFO and Secretary, Carole Ho, Chief Medical Officer, and Ryan Watts, President and CEO .
Denali Therapeutics Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||